Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Candida auris, a multidrug-resistant yeast that causes invasive infections, was first described in 2009 in Japan and has since been reported from several countries. METHODS: To understand the global emergence and epidemiology of C. auris, we obtained isolates from 54 patients with C. auris infection from Pakistan, India, South Africa, and Venezuela during 2012-2015 and the type specimen from Japan. Patient information was available for 41 of the isolates. We conducted antifungal susceptibility testing and whole-genome sequencing (WGS). RESULTS: Available clinical information revealed that 41% of patients had diabetes mellitus, 51% had undergone recent surgery, 73% had a central venous catheter, and 41% were receiving systemic antifungal therapy when C. auris was isolated. The median time from admission to infection was 19 days (interquartile range, 9-36 days), 61% of patients had bloodstream infection, and 59% died. Using stringent break points, 93% of isolates were resistant to fluconazole, 35% to amphotericin B, and 7% to echinocandins; 41% were resistant to 2 antifungal classes and 4% were resistant to 3 classes. WGS demonstrated that isolates were grouped into unique clades by geographic region. Clades were separated by thousands of single-nucleotide polymorphisms, but within each clade isolates were clonal. Different mutations in ERG11 were associated with azole resistance in each geographic clade. CONCLUSIONS: C. auris is an emerging healthcare-associated pathogen associated with high mortality. Treatment options are limited, due to antifungal resistance. WGS analysis suggests nearly simultaneous, and recent, independent emergence of different clonal populations on 3 continents. Risk factors and transmission mechanisms need to be elucidated to guide control measures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“C. auris, a novel Candida species first identified in 2009, has emerged since 2013 as a cause of nosocomial outbreaks in multiple countries across 5 continents.”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [16]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Resistance to all three classes of antifungals is reported most commonly in India in South Asia (3%), whereas this is much less common in other regions of the world.122–124”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [122]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Invasive C. auris infections are associated with high mortality rates, with 60% of hospitalizations due to C. auris infections resulting in death (8).”
From Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris : Results from a Phase 2 Trial (2023) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Three such mutations, encoding the amino acid substitutions VF125AL (commonly referred to as F126L), Y132F, and K143R, are frequently reported among fluconazole-resistant clinical isolates, and associations between these mutations and specific genetic clades of C. auris have been observed (2).”
From Mutations in TAC1B : a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris (2020) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, up to 96% of C. auris may exhibit resistance to fluconazole, an exceptionally high value compared to 0.5–2% for C. albicans, 4–9% for C. tropicalis, 2–6% for C. parapsilosis, and 11–13% for C. glabrata [16,40,41].”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [16]
Experimental — accuracy not yet measured
29 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0
Tamura, K., Stecher, G., Peterson, D., Filipski, A., & Kumar, S. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst197 · Cited by 47,205
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895 · cited 1×
“SNPs were identified using 2 independent pipelines, as described elsewhere (see also the legend to Supplemental Figure 1) [15, 19].”
MethodEpidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 2×
“auris because we did not have a comparison group of patients with other Candida infections from the same institutions [31].”
BackgroundResultNonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data
Chin, C.-S., Alexander, D. H., Marks, P., Klammer, A. A., Drake, J., Heiner, C., Clum, A., Copeland, A., Huddleston, J., Eichler, E. E., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2474 · Cited by 4,029 · cited 1×
“The reference genome was generated by de novo assembly of PacBio reads from isolate B8441, as described elsewhere [18], and used as a reference for single-nucleotide polymorphism (SNP) calling.”
MethodSatoh, K., Makimura, K., Hasumi, Y., Nishiyama, Y., Uchida, K., & Yamaguchi, H. (2009) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00083.x · Cited by 1,381 · cited 8×
“To understand the global emergence and epidemiology of C. auris, we obtained isolates from 54 patients with C. auris infection from Pakistan, India, South Africa, and Venezuela during 2012–2015 and the type specimen from Japan.”
BackgroundInfluentialEvolution of pathogenicity and sexual reproduction in eight Candida genomes
Butler, G., Rasmussen, M. D., Lin, M. F., Santos, M. A. S., Sakthikumar, S., Munro, C. A., Rheinbay, E., Grabherr, M., Forche, A., Reedy, J. L., et al. (2009) · Nature · doi:10.1038/nature08064 · Cited by 1,065 · cited 1×
“5 Mb, similar to that of other Candida species [25].”
BackgroundSelf-citationKathuria, S., Singh, P. K., Sharma, C., Prakash, A., Masih, A., Kumar, A., Meis, J. F., & Chowdhary, A. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00367-15 · Cited by 532 · cited 1×
“It phenotypically resembles Candida haemulonii and requires use of molecular methods for identification [9, 10].”
MethodSelf-citationFirst Three Reported Cases of Nosocomial Fungemia Caused by Candida auris
Lee, W. G., Shin, J. H., Uh, Y., Kang, M. G., Kim, S. H., Park, K. H., & Jang, H.-C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00319-11 · Cited by 523 · cited 2×
“auris [3], establishing that this new species was capable of causing invasive infections.”
BackgroundPerea, S., López-Ribot, J. L., Kirkpatrick, W. R., McAtee, R. K., Santillán, R. A., Martı́nez, M., Calabrese, D., Sanglard, D., & Patterson, T. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2676-2684.2001 · Cited by 470
Incidence, characteristics and outcome of ICU-acquired candidemia in India
Chakrabarti, A., Sood, P., Rudramurthy, S. M., Chen, S., Kaur, H., Capoor, M., Chhina, D., Rao, R., Eshwara, V. K., Xess, I., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-014-3603-2 · Cited by 454 · cited 1×
“auris may become widely established within certain regions, as evidenced by the fact that it now accounts for nearly 5% of candidemia in Indian intensive care units [5].”
Background
Cited by
Items 401–500 of 1,007
Candida auris in the UK: Introduction, dissemination, and control
Borman, A. M., & Johnson, E. M. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008563 · Cited by 49
“Subsequent outbreaks reported in the United Kingdom, Central and Southern Europe, and North America have all been seeded by isolates that can be mapped genetically to 1 of these 4 clonal lineages [6–8, 10–13].”
BackgroundInfluentialWeerasinghe, H., Simm, C., Djajawi, T. M., Tedja, I., Lo, T. L., Simpson, D. S., Shasha, D., Mizrahi, N., Olivier, F. A. B., Speir, M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112522 · Cited by 47
Ortiz-Roa, C., Valderrama-Ríos, M. C., Sierra-Umaña, S. F., Rodríguez, J. Y., Muñeton-López, G. A., Solórzano, C., Escandón, P., Álvarez, C., & Cortés, J. A. (2023) · Journal of Fungi · doi:10.3390/jof9070715 · Cited by 54
Wang, T. W., Sofras, D., Montelongo-Jauregui, D., Paiva, T. O., Carolus, H., Dufrêne, Y. F., Alfaifi, A. A., McCracken, C., Bruno, V. M., Van Dijck, P., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53588-5 · Cited by 47
Matsumura, Y., Yamamoto, M., Gomi, R., Tsuchido, Y., Shinohara, K., Noguchi, T., & Nagao, M. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00140-22 · Cited by 56
Dudiuk, C., Berrío, I., Leonardelli, F., Morales-López, S. E., Theill, L., Macedo, D., Rodríguez, J. Y., Salcedo, S., Marín, A., Gamarra, S. P., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz178 · Cited by 55
Dal Mas, C., Rossato, L., Shimizu, T., Oliveira, E. B., da Silva Junior, P. I., Meis, J. F., Colombo, A. L., & Hayashi, M. A. F. (2019) · Biomolecules · doi:10.3390/biom9060205 · Cited by 46
Self-citationMiesel, L., Lin, K., & Ong, V. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.546 · Cited by 47
Striking Back against Fungal Infections: The Utilization of Nanosystems for Antifungal Strategies
Du, W., Gao, Y., Liu, L., Sai, S., & Ding, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810104 · Cited by 52
Lara-Aguilar, V., Rueda, C., García-Barbazán, I., Varona, S., Monzón, S., Jiménez, P., Cuesta, I., Zaballos, Á., & Zaragoza, Ó. (2021) · Virulence · doi:10.1080/21505594.2021.1927609 · Cited by 40
“that this species clusters into five different clades [11,12,15,16].”
BackgroundBafghi, M. H., Zarrinfar, H., Darroudi, M., Zargar, M., & Nazari, R. (2022) · Letters in Applied Microbiology · doi:10.1111/lam.13667 · Cited by 48
“…estimated direct medical costs with increasing rate, are a widespread cause of lifethreatening systemic diseases and bloodstream infections in hospital patients and can be drug-resistant and challenging to treat (Lockhart et al. 2017; Arastehfar et al. 2019, 2021; Minooeianhaghighi et al. 2020).”
BackgroundSiopi, M., Peroukidou, I., Beredaki, M.-I., Spruijtenburg, B., de Groot, T., Meis, J. F. G. M., Vrioni, G., Tsakris, A., Pournaras, S., & Meletiadis, J. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04431-22 · Cited by 47
Self-citationDrug development challenges and strategies to address emerging and resistant fungal pathogens
McCarthy, M. W., & Walsh, T. J. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1328279 · Cited by 46
“agents as well as selection pressure, underscores the need for new therapeutic options and presents unique opportunities [3,96,97].”
BackgroundArastehfar, A., Fang, W., Daneshnia, F., Al-Hatmi, A. M., Liao, W., Pan, W., Khan, Z., Ahmad, S., Rosam, K., Lackner, M., et al. (2019) · Future Microbiology · doi:10.2217/fmb-2018-0227 · Cited by 41
Semreen, M. H., Soliman, S. S. M., Saeed, B. Q., Alqarihi, A., Uppuluri, P., & Ibrahim, A. S. (2019) · Molecules · doi:10.3390/molecules24030399 · Cited by 47
Leach, L., Russell, A., Zhu, Y., Chaturvedi, S., & Chaturvedi, V. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.00630-19 · Cited by 46
“Candida auris, an emerging multidrug-resistant yeast pathogen, continues to cause outbreaks and clusters of clinical cases worldwide (1, 2).”
BackgroundAugmenting the Activity of Chlorhexidine for Decolonization of Candida auris from Porcine skin
Johnson, C. J., Eix, E. F., Lam, B. C., Wartman, K. M., Meudt, J. J., Shanmuganayagam, D., & Nett, J. E. (2021) · Journal of Fungi · doi:10.3390/jof7100804 · Cited by 45
“auris isolates vary by geography and cluster into clades [1].”
BackgroundMethodInfluentialRole of Microbiota in the Skin Colonization of Candida auris
Tharp, B., Zheng, R., Bryak, G., Litvintseva, A. P., Hayden, M. K., Chowdhary, A., & Thangamani, S. (2023) · mSphere · doi:10.1128/msphere.00623-22 · Cited by 45
“This poses a significant challenge to treat infections caused by this fungal pathogen (5, 6).”
BackgroundSelf-citationImpact of Candida auris Infection in a Neutropenic Murine Model
Torres, S. R., Pichowicz, A., Torres-Velez, F., Song, R., Singh, N., Lasek-Nesselquist, E., & De Jesus, M. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01625-19 · Cited by 45
How to Identify Invasive Candidemia in ICU—A Narrative Review
Alves, J., Alonso-Tarrés, C., & Rello, J. (2022) · Antibiotics · doi:10.3390/antibiotics11121804 · Cited by 48
Recent Advances in Photodynamic Therapy against Fungal Keratitis
Hung, J., Lee, C., Hsu, H., Ng, I., Wu, C., Yu, C., Lee, N., Chang, Y. H., & Wong, T. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122011 · Cited by 50
“The emergence of drug resistance in fungal infection poses a significant threat to public health globally [5,6,30].”
BackgroundMalik, M. A., Batterjee, M. G., Kamli, M. R., Alzahrani, K. A., Danish, E. Y., & Nabi, A. (2022) · Journal of Fungi · doi:10.3390/jof8060639 · Cited by 48
A Fun-Guide to Innate Immune Responses to Fungal Infections
Burgess, T. B., Condliffe, A. M., & Elks, P. M. (2022) · Journal of Fungi · doi:10.3390/jof8080805 · Cited by 50
Biofilm-Associated Candidiasis: Pathogenesis, Prevalence, Challenges and Therapeutic Options
Amann, V., Kissmann, A., Firacative, C., & Rosenau, F. (2025) · Pharmaceuticals · doi:10.3390/ph18040460 · Cited by 48
Ahmad, A., Spencer, J. E., Lockhart, S. R., Singleton, S., Petway, D. J., Bagarozzi, D. A., & Herzegh, O. T. (2019) · Mycoses · doi:10.1111/myc.12907 · Cited by 43
Self-citationEmerging Issues in Antifungal Resistance
Perfect, J. R., & Ghannoum, M. (2020) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2020.05.003 · Cited by 47
Candida auris undergoes adhesin-dependent and -independent cellular aggregation
Pelletier, C., Shaw, S., Alsayegh, S., Brown, A. J. P., & Lorenz, A. (2024) · PLOS Pathogens · doi:10.1371/journal.ppat.1012076 · Cited by 44
MycoSNP: A Portable Workflow for Performing Whole-Genome Sequencing Analysis of Candida auris
Bagal, U. R., Phan, J., Welsh, R. M., Misas, E., Wagner, D., Gade, L., Litvintseva, A. P., Cuomo, C. A., & Chow, N. A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2417-3_17 · Cited by 44
Self-citationBiran, R., Cohen, R., Finn, T., Brosh-Nissimov, T., Rahav, G., Yahav, D., Amit, S., Shachor-Meyouhas, Y., Atamna, A., Bishara, J., et al. (2023) · Emerging Infectious Diseases · doi:10.3201/eid2907.221888 · Cited by 39
Update on therapeutic approaches for invasive fungal infections in adults
Boutin, C.-A., & Luong, M. (2024) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361231224980 · Cited by 54
“33 Several factors contribute to its recent rise, including increase in international travel, drug pressure, and challenges associated with its laboratory identification.”
BackgroundWeber, D. J., Sickbert-Bennett, E. E., Kanamori, H., & Rutala, W. A. (2019) · American Journal of Infection Control · doi:10.1016/j.ajic.2019.03.004 · Cited by 46
A Selective Medium for Isolation and Detection of Candida auris, an Emerging Pathogen
Das, S. K., Singh, S., Tawde, Y., Chakrabarti, A., Rudramurthy, S. M., Kaur, H., Shankarnarayan, S. A., & Ghosh, A. K. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00326-20 · Cited by 44
“infection has been reported from six continents (2, 3).”
BackgroundSharp, A., Müller‐Pebody, B., Charlett, A., Patel, B., Gorton, R., Lambourne, J., Cummins, M. N., Alcolea-Medina, A., Wilks, M., Smith, R., et al. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.8.1900730 · Cited by 43
“Cases of C. auris have been reported on five continents, with outbreaks reported in India, Pakistan, South Africa and Venezuela [4].”
BackgroundInfluentialKovács, R., Tóth, Z., Locke, J. B., Forgács, L., Kardos, G., Nagy, F., Borman, A. M., & Majoros, L. (2021) · Microorganisms · doi:10.3390/microorganisms9040863 · Cited by 46
Naicker, S. D., Maphanga, T. G., Chow, N. A., Allam, M., Kwenda, S., Ismail, A., & Govender, N. P. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1944323 · Cited by 46
“tericin B [3], and causes outbreaks in healthcare settings [4].”
InfluentialSelf-citationAntifungal activity of nitroxoline against Candida auris isolates
Fuchs, F., Hof, H., Hofmann, S., Kurzai, O., Meis, J. F. G. M., & Hamprecht, A. G. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.06.035 · Cited by 46
Self-citationMarena, G. D., Ramos, M. A. D. S., de Lima, L. C., Chorilli, M., & Bauab, T. M. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.151023 · Cited by 43
Emerging and future strategies in the management of recalcitrant Candida auris
Bandara, N., & Samaranayake, L. P. (2022) · Medical Mycology · doi:10.1093/mmy/myac008 · Cited by 50
“…the consensus is that C. auris associated candidemias nd septicemias could lead to in-hospital crude mortality rates s high as 72%.25 A study by Lockhart et al. (2017) clearly illustrates the alarmng breadth and depth of this problem.15 They noted that alost one half of all C. auris isolates…”
Public Health Research Priorities for Fungal Diseases: A Multidisciplinary Approach to Save Lives
Smith, D. J., Gold, J. A. W., Benedict, K., Wu, K., Lyman, M., Jordan, A., Medina, N., Lockhart, S. R., Sexton, D. J., Chow, N. A., et al. (2023) · Journal of Fungi · doi:10.3390/jof9080820 · Cited by 48
“auris isolates reported in the United States and globally is increasing, but research is needed to understand outcomes and appropriate treatment, particularly for these pan-resistant isolates [55,56].”
BackgroundSelf-citationSokou, R., Palioura, A. E., Taliaka, P. K., Konstantinidi, A., Tsantes, A. G., Piovani, D., Tsante, K. A., Gounari, E. A., Iliodromiti, Z., Boutsikou, Τ., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061586 · Cited by 47
Solu: a cloud platform for real-time genomic pathogen surveillance
Saratto, T., Visuri, K., Lehtinen, J., Ortega-Sanz, I., Steenwyk, J. L., & Sihvonen, S. (2025) · BMC Bioinformatics · doi:10.1186/s12859-024-06005-z · Cited by 48
Khan, Z., Ahmad, S., Mokaddas, E., Meis, J. F., Joseph, L., Abdullah, A., & Vayalil, S. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01926-17 · Cited by 42
Self-citationCandida auris outbreak involving liver transplant recipients in a surgical intensive care unit
Theodoropoulos, N. M., Bolstorff, B., Bozorgzadeh, A., Brandeburg, C., Cumming, M., Daly, J. S., Ellison, R. T., Forsberg, K., Gade, L., Gibson, L., et al. (2020) · American Journal of Transplantation · doi:10.1111/ajt.16144 · Cited by 41
Self-citationBeat the heat: correlates, compounds, and mechanisms involved in fungal thermotolerance
Mattoon, E. R., Casadevall, A., & Cordero, R. J. B. (2021) · Fungal Biology Reviews · doi:10.1016/j.fbr.2021.03.002 · Cited by 45
Antifungal Development and the Urgency of Minimizing the Impact of Fungal Diseases on Public Health
de Oliveira, H. C., Bezerra, B. T., & Rodrigues, M. L. (2022) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.2c00055 · Cited by 46
Sanglard, D. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007478 · Cited by 42
Comparative Transcriptomics Reveal Possible Mechanisms of Amphotericin B Resistance in Candida auris
Shivarathri, R., Jenull, S., Chauhan, M., Singh, A., Mazumdar, R., Chowdhary, A., Kuchler, K., & Chauhan, N. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02276-21 · Cited by 41
Self-citationEix, E. F., Johnson, C. J., Wartman, K. M., Kernien, J. F., Meudt, J. J., Shanmuganayagam, D., Gibson, A. L. F., & Nett, J. E. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac094 · Cited by 41
Whole genome sequence of first Candida auris strain, isolated in Russia
Pchelin, I. M., Валерьевич, А. Д., Churina, M. A., Ryabinin, I. A., Vybornova, I. V., Апалько, С. В., Kruglov, A., Sarana, А. М., Taraskina, A. E., & Vasilyeva, N. V. (2019) · Medical Mycology · doi:10.1093/mmy/myz078 · Cited by 42
Oliva, A., Rosa, F. G. D., Mikulska, M., Pea, F., Sanguinetti, M., Tascini, C., & Venditti, M. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2240956 · Cited by 51
Antifungal stewardship: developments in the field
Urbancic, K. F., Thursky, K., Kong, D. C. M., Johnson, P. D. R., & Slavin, M. A. (2018) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000497 · Cited by 41
Farnesol increases the activity of echinocandins against Candida auris biofilms
Nagy, F., Tóth, Z., Daróczi, L., Székely, A., Borman, A. M., Majoros, L., & Kovács, R. (2019) · Medical Mycology · doi:10.1093/mmy/myz057 · Cited by 42
Iyer, K. R., Whitesell, L. J., Porco, J. A. J., Henkel, T. O., Brown, L. E., Robbins, N., & Cowen, L. E. (2020) · mBio · doi:10.1128/mbio.03329-19 · Cited by 48
Advances in fungal chemical genomics for the discovery of new antifungal agents
Xue, A., Robbins, N., & Cowen, L. E. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14484 · Cited by 43
Skin Metagenomic Sequence Analysis of Early Candida auris Outbreaks in U.S. Nursing Homes
Huang, X., Welsh, R. M., Deming, C., Proctor, D. M., Thomas, P. J., Program, N. C. S., Gussin, G. M., Huang, S. S., Kong, H. H., Bentz, M. L., et al. (2021) · mSphere · doi:10.1128/msphere.00287-21 · Cited by 43
“antifungals (azoles, amphotericin B, and echinocandins) (2, 11).”
BackgroundSelf-citationFungicidal Potency and Mechanisms of θ-Defensins against Multidrug-Resistant Candida Species
Basso, V., Garcia, A., Tran, D. Q., Schaal, J. B., Tran, P. A., Ngole, D., Aqeel, Y., Tongaonkar, P., Ouellette, A. J., & Selsted, M. E. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00111-18 · Cited by 44
Castanheira, M., Deshpande, L. M., Rhomberg, P. R., & Carvalhaes, C. G. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00570-24 · Cited by 44
“We observed the Erg11 alterations Y132F and/or K143R in isolates from Clades I and IV and the F126L alteration in isolates from Clade III; these alterations are known to confer fluconazole resistance and only occur in these specific Clades (2, 18).”
BackgroundInfluentialSelf-citationCandida auris:a fungus with identity crisis
Vila, T. V. M., Sultan, A. S., Montelongo‐Jauregui, D., & Jabra‐Rizk, M. A. (2020) · Pathogens and Disease · doi:10.1093/femspd/ftaa034 · Cited by 41
Candida auris Urinary Tract Infections and Possible Treatment
Griffith, N. C., & Danziger, L. H. (2020) · Antibiotics · doi:10.3390/antibiotics9120898 · Cited by 48
“Fluconazole resistance mechanisms are not completely understood, but are known to include EGR11 mutations and duplications, as well as efflux pumps [18,19].”
BackgroundAspergillus fumigatus Cross-Resistance between Clinical and Demethylase Inhibitor Azole Drugs
Garcia‐Rubio, R., González-Jiménez, I., Lucio, J. L., & Mellado, E. (2020) · Applied and Environmental Microbiology · doi:10.1128/aem.02539-20 · Cited by 41
Karmarkar, E. N., O’Donnell, K., Prestel, C., Forsberg, K., Gade, L., Jain, S., Schan, D., Chow, N., McDermott, D., Rossow, J., et al. (2021) · Annals of Internal Medicine · doi:10.7326/m21-2013 · Cited by 38
“Most C auris isolates are resistant to fluconazole, and resistance to amphotericin B and echinocandins has already been identified in C auris strains globally and in the United States (3, 4, 10), making C auris amultidrug-resistant organism (MDRO) of concern.”
BackgroundResultInfluentialSelf-citationApplication of Machine Learning Classifier to Candida auris Drug Resistance Analysis
Li, D., Wang, Y., Hu, W., Chen, F., Zhao, J., Chen, X., & Li, H. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.742062 · Cited by 40
“Three candidate gene sets were selected in this study (Lockhart et al., 2017; Munoz et al., 2018; Chaabane et al., 2019; Rybak et al., 2020) (Table S2).”
BackgroundMethodResultMirhendi, H., Charsizadeh, A., Aboutalebian, S., Mohammadpour, M., Nikmanesh, B., de Groot, T., Meis, J. F. G. M., & Badali, H. (2021) · Mycoses · doi:10.1111/myc.13396 · Cited by 46
Self-citationOverview about Candida auris: What's up 12 years after its first description?
Désoubeaux, G., Coste, A. T., Imbert, C., & Hennequin, C. (2022) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2022.101248 · Cited by 43
Stevenson, E. M., Gaze, W. H., Gow, N. A. R., Hart, A. J., Schmidt, W., Usher, J., Warris, A., Wilkinson, H., & Murray, A. K. (2022) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2022.918717 · Cited by 42
“On the other hand, acquired resistance typically follows exposure to antimicrobial selective pressures, and may be caused by mutations, genome rearrangements and/or overexpression of resistance gene products (Lockhart et al., 2017; Chaabane et al., 2019; Berman and Krysan, 2020) (Figure 3).”
BackgroundAl-Obaid, I., Asadzadeh, M., Ahmad, S., Alobaid, K., Alfouzan, W., Bafna, R., Emara, M., & Joseph, L. (2022) · Journal of Fungi · doi:10.3390/jof8030267 · Cited by 39
“auris strains belong to one of five Clades which differ in thousands of single nucleotide polymorphisms and exhibit considerable differences in their intrinsic susceptibility to antifungal drugs [44,54].”
BackgroundCandida auris: Epidemiology Update and a Review of Strategies to Prevent Spread
Hayes, J. F. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13226675 · Cited by 45
Begerow, D., Kemler, M., Feige, A., & Yurkov, A. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-61575-2_7 · Cited by 39
Kurt, A. F., Kuşkucu, M. A., Balkan, I. I., Barış, A., Yazgan, Z., Oz, A. S., Tosun, A. İ., Mete, B., Tabak, F., & Aygün, G. (2021) · Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2021.03.007 · Cited by 42
Govender, N. P., Avenant, T., Brink, A. J., Chibabhai, V., Cleghorn, J., du Toit, B., Govind, C., Lewis, E., Lowman, W., Mahlangu, H., et al. (2019) · Southern African Journal of Infectious Diseases · doi:10.4102/sajid.v34i1.163 · Cited by 46
Self-citationPotential Environmental Reservoirs of Candida auris: A Systematic Review
da Silva, I. C. B., Miranda, I. M., & Costa‐de‐Oliveira, S. (2024) · Journal of Fungi · doi:10.3390/jof10050336 · Cited by 43
“In 2022, the World Health Organization designated this fungal pathogen as a priority due to its rapid transmission in healthcare settings and high mortality rate [5,6].”
BackgroundNew antifungal strategies and drug development against WHO critical priority fungal pathogens
Li, Y., Liu, Y., Jiang, Y., Yang, Y., Ni, W., Zhang, W., & Tan, L. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1662442 · Cited by 53
“…use of antifungal agents, resistance among Candida species has become increasingly concerning, especially with the emergence of multidrug-resistant strains such as Candida auris , now recognized as a global health threat (Clancy and Nguyen, 2016; Lockhart et al., 2017; Rhodes and Fisher, 2019).”
First case of Candida auris in Switzerland: discussion about preventive strategies
Riat, A., Neofytos, D., Coste, A. T., Harbarth, S., Bizzini, A., Grandbastien, B., Pugin, J., & Lamoth, F. (2018) · Swiss Medical Weekly · doi:10.4414/smw.2018.14622 · Cited by 37
Pfaller, M. A., Messer, S. A., Deshpande, L. M., Rhomberg, P. R., Utt, E. A., & Castanheira, M. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02031-20 · Cited by 37
Self-citationMaphanga, T. G., Mpembe, R. S., Naicker, S. D., Govender, N. P., & GERMS-SA, F. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01717-21 · Cited by 42
“We aligned the paired-end reads data to a South African C. auris strain (B11221), which had been previously sequenced on the PacBio platform by Lockhart et al. in 2017, using BurrowsWheeler Aligner (BWA) (9).”
Self-citationCandida auris infections in China
Du, H., Bing, J., Nobile, C. J., & Huang, G. (2022) · Virulence · doi:10.1080/21505594.2022.2054120 · Cited by 40
“are even resistant to all three of the major classes of antifungal drugs (the azoles, the polyenes, and the echinocandins) [2,7].”
BackgroundSimm, C., Weerasinghe, H., Thomas, D. R., Harrison, P. F., Newton, H. J., Beilharz, T. H., & Traven, A. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00100-22 · Cited by 38
Wiederhold, N. P. (2021) · Journal of Fungi · doi:10.3390/jof7020130 · Cited by 37
“Recently, the problem of antifungal resistance has been highlighted by the emergence of Candida auris, as many strains of this clinically significant pathogen are multidrug-resistant [5], and pan-antifungal resistance has also been reported [6,7].”
BackgroundWhat Is New in Fungal Infections?
Parsons, M. G., & Diekema, D. J. (2023) · Modern Pathology · doi:10.1016/j.modpat.2023.100187 · Cited by 40
Kekana, D., Naicker, S. D., Shuping, L., Velaphi, S., Nakwa, F. L., Wadula, J., Govender, N. P., & GERMS-SA1, F. (2023) · Emerging infectious diseases · doi:10.3201/eid2910.230181 · Cited by 42
“Globally, echinocandin-resistant isolates are not as prevalent as azole-and polyene-resistant isolates, which is partly why echinocandins are recommended as first-line treatment ( 5 ).”
BackgroundSelf-citationChanges in fungal taxonomy: mycological rationale and clinical implications
Borman, A. M., & Johnson, E. M. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00099-22 · Cited by 41
Brassington, P. J. T., Klefisch, F.-R., Graf, B., Pfüller, R., Kurzai, O., Walther, G., & Barber, A. E. (2024) · The Lancet Microbe · doi:10.1016/j.lanmic.2024.07.012 · Cited by 42
Hashemi, M., Rovig, J., Holden, B., Taylor, M., Weber, S., Wilson, J., Hilton, B., Zaugg, A. L., Ellis, S. W., Yost, C. D., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky085 · Cited by 38
Self-citationRole of lipid transporters in fungal physiology and pathogenicity
Rizzo, J., Stanchev, L. D., Silva, V. K. A., Nimrichter, L., Pomorski, T. G., & Rodrigues, M. L. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.09.001 · Cited by 39
Stavrou, A. A., Hansen, A. P., Lackner, M., Lass‐Flörl, C., & Boekhout, T. (2020) · Medical Mycology · doi:10.1093/mmy/myaa005 · Cited by 38
Zhu, Y. C., Barat, S., Borroto–Esoda, K., Angulo, D., Chaturvedi, S., & Chaturvedi, V. P. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105922 · Cited by 40
NO Candida auris: Nitric Oxide in Nanotherapeutics to Combat Emerging Fungal Pathogen Candida auris
Cleare, L. G., Li, K. L., Abuzeid, W. M., Nacharaju, P., Friedman, J. M., & Nosanchuk, J. D. (2020) · Journal of Fungi · doi:10.3390/jof6020085 · Cited by 36
“It is further notable that 41% of isolates were resistant to two separate antifungal classes and 4% were resistant to all three antifungal classes [2,20].”
BackgroundOn the Origin of Candida auris: Ancestor, Environmental Stresses, and Antiseptics
Sharma, M., & Chakrabarti, A. (2020) · mBio · doi:10.1128/mbio.02102-20 · Cited by 35
“The four distinct clades emerged almost simultaneously on different continents, but it is not known if all had a common ancestor (4).”
BackgroundNovel Therapeutic Approaches to Invasive Candidiasis: Considerations for the Clinician
Lamoth, F. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s375625 · Cited by 43
High-Throughput Profiling of Candida auris Isolates Reveals Clade-Specific Metabolic Differences
Brandt, P., Mirhakkak, M. H., Wagner, L., Driesch, D., Möslinger, A., Fänder, P., Schäuble, S., Panagiotou, G., & Vylkova, S. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00498-23 · Cited by 39
The evolution of antifungal therapy: Traditional agents, current challenges and future perspectives
de Souza, C. M., Bezerra, B. T., Mellon, D. A., & de Oliveira, H. C. (2025) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2025.100341 · Cited by 53
Allison, D. L., Scheres, N., Willems, H. M. E., Bode, C. S., Krom, B. P., & Shirtliff, M. E. (2019) · Infection and Immunity · doi:10.1128/iai.00137-19 · Cited by 39
“The formation of biofilms on devitalized tissues, on medical devices, and within immunocompromised patients continues to burden health care communities worldwide; biofilm-mediated infections account for about 25% of all nosocomial infections (4, 5).”
BackgroundChitosan Ameliorates Candida auris Virulence in a Galleria mellonella Infection Model
Arias, L. S., Butcher, M. C., Short, B., McKloud, E., Delaney, C., Kean, R., Monteiro, D. R., Williams, C., Ramage, G., & Brown, J. L. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00476-20 · Cited by 39
Derivates of the Antifungal Peptide Cm-p5 Inhibit Development of Candida auris Biofilms In Vitro
Kubiczek, D. H., Raber, H. F., González-García, M., Morales-Vicente, F., Ständker, L., Otero‐González, A. J., & Rosenau, F. (2020) · Antibiotics · doi:10.3390/antibiotics9070363 · Cited by 38
“It causes severe invasive infections in hospitalized patients, which lead to high mortality rates between 35 and 60% [7,8].”
BackgroundPhotodynamic Therapy Is Effective Against Candida auris Biofilms
Bapat, P. S., & Nobile, C. J. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.713092 · Cited by 35
“auris clinical isolates have been reported to be resistant to one or more of the three major classes of antifungal drugs used to treat invasive fungal infections, with 90% resistant to at least one antifungal drug class, 30% resistant to at least two antifungal drug classes, and a handful displaying pan-resistance to…”
BackgroundMethodInfluentialA Chronic Autochthonous Fifth Clade Case of Candida auris Otomycosis in Iran
Safari, F., Madani, M., Badali, H., Kargoshaie, A.-A., Fakhim, H., Kheirollahi, M., Meis, J. F. G. M., & Mirhendi, H. (2021) · Mycopathologia · doi:10.1007/s11046-021-00605-6 · Cited by 42
Self-citationGalia, L., Pezzani, M. D., Compri, M., Callegari, A., Rajendran, N. B., Carrara, E., Tacconelli, E., & the COMBACTE MAGNET EPI-Net Network (2022) · Journal of Fungi · doi:10.3390/jof8030249 · Cited by 38
Candida auris Blood stream infection- a descriptive study from Qatar
Koleri, J., Petkar, H. M., Soub, H. A. R. S. A., & Almaslamani, M. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08477-5 · Cited by 42
Narayanan, A., Kumar, P., Chauhan, A., Kumar, M., Yadav, K., Banerjee, A., Sharma, R. D., Rudramurthy, S. M., Chakrabarti, A., Sanyal, K., et al. (2022) · mBio · doi:10.1128/mbio.03052-22 · Cited by 35
Efficacy of Curcumin-Mediated Antimicrobial Photodynamic Therapy on Candida spp.—A Systematic Review
Kubizna, M., Dawiec, G., & Wiench, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158136 · Cited by 36
“It is known to cause invasive infections in immunocompromised patients, particularly in hospital wards [9].”
Background
Metadata
- Authors
- Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., Berkow, E. L., Castanheira, M., Magobo, R. E., Jabeen, K., Asghar, R. J., Meis, J. F., Jackson, B., Chiller, T., & Litvintseva, A. P.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Aga Khan University (PK)
- University of Delhi (IN)
- National Health Laboratory Service (ZA)
- Universidade Federal de São Paulo (BR)
- Universidad del Zulia (VE)
- Broad Institute (US)
- JMI Laboratories (US)
- Radboud University Nijmegen (NL)
- ORCID
- Lockhart, Shawn R.
- Vallabhaneni, Snigdha
- Farooqi, Joveria
- Chowdhary, Anuradha
- Govender, Nelesh P.
- Colombo, Arnaldo Lopes
- Cuomo, Christina A.
- Desjardins, Christopher A.
- Berkow, Elizabeth L.
- Castanheira, Mariana
- Magobo, Rindidzani E.
- Jabeen, Kauser
- Asghar, Rana J.
- Meis, Jacques F.
- Jackson, Brendan
- Chiller, Tom
- Litvintseva, Anastasia P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-10-20
- Volume
- 64
- Issue
- 2
- Pages
- 134-140
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC5215215
- OpenAlex
- W2536287248
- Semantic Scholar
- c8d8e54651d8fb7a7ece68270cd2630d1cd0df39
- Cited by
- 1,662
- References
- 32
- Citations by year
- 2026: 196 · 2025: 194 · 2024: 203 · 2023: 186 · 2022: 160 · 2021: 178 · 2020: 187 · 2019: 152 · 2018: 116 · 2017: 81 · 2016: 5
- FWCI
- 108.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- public-domain
- Locations
- Clinical Infectious Diseases (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- UNIFESP Institutional Repository (Universidade Federal de São Paulo) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (U19AI110818)
- United States Agency for International Development (4-338/PAK-US/HEC/2010/932)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- Candida auris, multidrug resistance, antifungal resistance, clonal populations, ERG11 mutations, azole resistance, fluconazole resistance, bloodstream infection, invasive candidiasis, nosocomial infections, risk factors, transmission, whole genome sequencing, antifungal susceptibility
- MeSH terms
- Whole Genome Sequencing, Adolescent, Adult, Aged, Antifungal Agents, Candida, Candidiasis, Child, Child, Preschool, Cytochrome P-450 Enzyme System, Female, Humans, Infant, Infant, Newborn, Male, Microbial Sensitivity Tests, Middle Aged, Mutation, Phylogeny, RNA, Ribosomal, 28S, Global Health, Genome, Fungal, Drug Resistance, Multiple, Polymorphism, Single Nucleotide, DNA, Ribosomal Spacer, Drug Resistance, Fungal, Young Adult, Candidemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.